A common medication used to manage and treat HIV is becoming increasingly resistant, according to a report from the World Health Organization. Dolutegravir is an antiretroviral medication that is ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
GSK's antiretroviral HIV medicine Tivicay (dolutegravir) has been recommended by the World Health Organization (WHO) since 2018 as a preferred treatment for the virus. Now, the same agency is flagging ...
HIV virus is one of the most pressing health concerns facing the modern world. Since the first reported case of HIV/AIDS in 1981, over 25 million people have died. Out of the millions of people ...
Just as life is ever-evolving, so is the HIV treatment landscape. Thanks to decades of therapeutic improvements, people with HIV are living longer, healthier lives, but additional treatment needs may ...
LOS ANGELES — Lenacapavir, the twice-yearly injectable HIV drug, could potentially transform HIV prevention if it is approved as PrEP, research has shown. In the meantime, the drug is already approved ...
Effect of the Initial Regimen on the Rate of Specific Mutations Even among different HAART regimens, the selection of the initial regimen also has important implications in terms of selecting for ...
Two studies presented at this year's resistance meeting examined the clinical utility of resistance testing in prospective, randomized trials. Results of these studies are equivocal and raise ...
The announcement of the cuts prompted warnings from around the world about the potential consequences. In the Journal of ...
The entry of HIV-1 into host cells is mediated by precise interactions between viral envelope glycoproteins and cellular receptors. Fusion inhibitors, which disrupt these interactions—particularly by ...
WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback